Nexstim Plc (NXTMH) - Financial and Strategic SWOT Analysis Review
Description
Nexstim Plc (NXTMH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Nexstim Plc (Nexstim) is a medical technology company. It focuses on developing non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS). The company offers advanced systems for presurgical mapping and therapeutic applications. Its major products are the NBS System for diagnostics and the NBT System for therapy, both of which are used in neurosurgical planning and the treatment of depressive disorder and chronic neuropathic pain. The company also develops products based on its proprietary SmartFocus TMS technology. Nexstim's technology is utilized by healthcare facilities for precise brain mapping and treatment, catering to the needs of neurosurgeons and mental health professionals. The company operates through subsidiaries in the US and Germany. Nexstim is headquartered in Helsinki, Finland.
Nexstim Plc Key Recent Developments
Mar 23,2026: Nexstim’s NBS System 6 Receives FDA Clearance for Obsessive Compulsive Disorder Treatment
Mar 23,2026: Nexstim’s NBS System 6 Gains FDA Clearance for Adolescent Depression Treatment
Mar 10,2026: University Hospital in Finland Orders Nexstim NBS 6 System
Feb 26,2026: NEXSTIM OYJ Annual Financial Statement 2025
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Nexstim Plc (Nexstim) is a medical technology company. It focuses on developing non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS). The company offers advanced systems for presurgical mapping and therapeutic applications. Its major products are the NBS System for diagnostics and the NBT System for therapy, both of which are used in neurosurgical planning and the treatment of depressive disorder and chronic neuropathic pain. The company also develops products based on its proprietary SmartFocus TMS technology. Nexstim's technology is utilized by healthcare facilities for precise brain mapping and treatment, catering to the needs of neurosurgeons and mental health professionals. The company operates through subsidiaries in the US and Germany. Nexstim is headquartered in Helsinki, Finland.
Nexstim Plc Key Recent Developments
Mar 23,2026: Nexstim’s NBS System 6 Receives FDA Clearance for Obsessive Compulsive Disorder Treatment
Mar 23,2026: Nexstim’s NBS System 6 Gains FDA Clearance for Adolescent Depression Treatment
Mar 10,2026: University Hospital in Finland Orders Nexstim NBS 6 System
Feb 26,2026: NEXSTIM OYJ Annual Financial Statement 2025
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
50 Pages
- Section 1 - About the Company
- Nexstim Plc - Key Facts
- Nexstim Plc - Key Employees
- Nexstim Plc - Key Employee Biographies
- Nexstim Plc - Major Products and Services
- Nexstim Plc - History
- Nexstim Plc - Company Statement
- Nexstim Plc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- Nexstim Plc - Business Description
- Product Category: Diagnostics recurring
- Performance
- Product Category: Diagnostics system
- Performance
- Product Category: Research & neuroscience licensing
- Performance
- Product Category: Research & neuroscience recurring
- Performance
- Product Category: Research & neuroscience system
- Performance
- Product Category: Therapy recurring
- Performance
- Product Category: Therapy system
- Performance
- Geographical Segment: Finland
- Performance
- Geographical Segment: North America
- Performance
- Geographical Segment: Other
- Performance
- Geographical Segment: Rest of Europe
- Performance
- Nexstim Plc - Corporate Strategy
- Nexstim Plc - SWOT Analysis
- SWOT Analysis - Overview
- Nexstim Plc - Strengths
- Nexstim Plc - Weaknesses
- Nexstim Plc - Opportunities
- Nexstim Plc - Threats
- Nexstim Plc - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- Nexstim Plc, Medical Equipment, Deals By Year, 2020 to YTD 2026
- Nexstim Plc, Medical Equipment, Deals By Type, 2020 to YTD 2026
- Nexstim Plc, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Mar 23, 2026: Nexstim’s NBS System 6 Receives FDA Clearance for Obsessive Compulsive Disorder Treatment
- Mar 23, 2026: Nexstim’s NBS System 6 Gains FDA Clearance for Adolescent Depression Treatment
- Mar 10, 2026: University Hospital in Finland Orders Nexstim NBS 6 System
- Feb 26, 2026: NEXSTIM OYJ Annual Financial Statement 2025
- Feb 19, 2026: Nexstim NBS 6 Receives MDR Certification in EU for Post-Operative Rehabilitation
- Feb 02, 2026: Nexstim Receives System Order From Distributor in India
- Dec 29, 2025: Nexstim Receives NBS 6 System Order From New US Customer
- Dec 23, 2025: Nexstim Oyj Agrees to Next Phase of Exclusive Agreement With Sinaptica Therapeutics, Inc.
- Dec 16, 2025: Finnish Private Clinic Group Orders Two Nexstim NBS 6 Systems
- Dec 15, 2025: Nexstim Receives NBS 6 Therapy System Order From US Customer
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Nexstim Plc, Key Facts
- Nexstim Plc, Key Employees
- Nexstim Plc, Key Employee Biographies
- Nexstim Plc, Major Products and Services
- Nexstim Plc, History
- Nexstim Plc, Subsidiaries
- Nexstim Plc, Key Competitors
- Nexstim Plc, Ratios based on current share price
- Nexstim Plc, Annual Ratios
- Nexstim Plc, Annual Ratios (Cont...1)
- Nexstim Plc, Annual Ratios (Cont...2)
- Nexstim Plc, Interim Ratios
- Nexstim Plc, Medical Equipment, Deals By Year, 2020 to YTD 2026
- Nexstim Plc, Medical Equipment, Deals By Type, 2020 to YTD 2026
- Nexstim Plc, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Nexstim Plc, Performance Chart (2021 - 2025)
- Nexstim Plc, Ratio Charts
- Nexstim Plc, Medical Equipment, Deals By Year, 2020 to YTD 2026
- Nexstim Plc, Medical Equipment, Deals by Type, 2020 to YTD 2026
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
